Javascript must be enabled to continue!
Is better early closure compared to late closure of temporary ileostomy in rectal cancer? A randomized controlled trial study
View through CrossRef
Abstract
Purpose
A temporary loop ileostomy is one of the most common methods for the prevention of anastomotic leakage in rectal cancer patients who underwent low anterior resection. However, the optimal timing of loop ileostomy reversal remains unknown. The main purpose of this study is to assess the suitable time for a reversal of temporary loop ileostomy in rectal cancer patients.
Methods
We conducted a prospective, randomized trial at Sina Hospital, Tehran, Iran from 2020 to 2021 to determine the appropriate time for closure of temporary loop ileostomy in rectal cancer patients who underwent low anterior resection.
Results
The results of this prospective randomized controlled trial are as shown: significantly difference in body mass index, the time interval between creation and closure of stoma, and distance from last chemotherapy. No significant difference was found between the two groups in terms of complications based on the Clavien-Dindo classification. As well as, there is no significant difference in perioperative outcomes, such as blood loss, operative time, re-admission, and re-operation. Also, statistically significant differences had reported between patients' quality of life and LARS score.
Conclusion
In summary, it seems that early closure of ileostomy is generally effective and safe in reducing the risk of complications and improving quality of life in patients with rectal cancer following low anterior resection and chemotherapy (neoadjuvant and adjuvant).
Trial registration number and date of registration:
IRCT20201113049373N1 (January 2,2021)
Research Square Platform LLC
Title: Is better early closure compared to late closure of temporary ileostomy in rectal cancer? A randomized controlled trial study
Description:
Abstract
Purpose
A temporary loop ileostomy is one of the most common methods for the prevention of anastomotic leakage in rectal cancer patients who underwent low anterior resection.
However, the optimal timing of loop ileostomy reversal remains unknown.
The main purpose of this study is to assess the suitable time for a reversal of temporary loop ileostomy in rectal cancer patients.
Methods
We conducted a prospective, randomized trial at Sina Hospital, Tehran, Iran from 2020 to 2021 to determine the appropriate time for closure of temporary loop ileostomy in rectal cancer patients who underwent low anterior resection.
Results
The results of this prospective randomized controlled trial are as shown: significantly difference in body mass index, the time interval between creation and closure of stoma, and distance from last chemotherapy.
No significant difference was found between the two groups in terms of complications based on the Clavien-Dindo classification.
As well as, there is no significant difference in perioperative outcomes, such as blood loss, operative time, re-admission, and re-operation.
Also, statistically significant differences had reported between patients' quality of life and LARS score.
Conclusion
In summary, it seems that early closure of ileostomy is generally effective and safe in reducing the risk of complications and improving quality of life in patients with rectal cancer following low anterior resection and chemotherapy (neoadjuvant and adjuvant).
Trial registration number and date of registration:
IRCT20201113049373N1 (January 2,2021).
Related Results
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Staged Turnbull-Cutait Pull-through Anastomosis Comparing With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection (STAR-TAR):study protocol for a randomized controlled trial
Staged Turnbull-Cutait Pull-through Anastomosis Comparing With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection (STAR-TAR):study protocol for a randomized controlled trial
Abstract
Background
Recent advancements in the understanding of lower rectum anatomy, rectal cancer biology, and surgical techniques have emphasized the importance of radic...
A COMPARATIVE STUDY BETWEEN THE OUTCOME OF PRIMARY REPAIR VERSUS LOOP ILEOSTOMY IN ILEAL PERFORATION
A COMPARATIVE STUDY BETWEEN THE OUTCOME OF PRIMARY REPAIR VERSUS LOOP ILEOSTOMY IN ILEAL PERFORATION
Background: Ileal perforation is a critical surgical emergency associated with high morbidity and mortality if treatment is delayed. Among the management strategies, primary repair...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...

